Authors:
Salahudeen, AK
Fleischmann, E
Ahmed, A
Bower, JD
Citation: Ak. Salahudeen et al., Anemia and iron target realization in 1998: Clinical management of anemia in 1,639 patients on hemodialysis, ASAIO J, 47(5), 2001, pp. 511-515
Citation: Eh. Fleischmann et al., Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?, CLIN NEPHR, 56(3), 2001, pp. 221-230
Authors:
Maung, HM
Elangovan, L
Frazao, JM
Bower, JD
Kelley, BJ
Acchiardo, SR
Rodriguez, HJ
Norris, KC
Sigala, JF
Rutkowski, M
Robertson, JA
Goodman, WG
Levine, BS
Chesney, RW
Mazess, RB
Kyllo, DM
Douglass, LL
Bishop, CW
Coburn, JW
Citation: Hm. Maung et al., Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison, AM J KIDNEY, 37(3), 2001, pp. 532-543
Authors:
Salahudeen, AK
Oliver, B
Bower, JD
Roberts, LJ
Citation: Ak. Salahudeen et al., Increase in plasma esterified F-2-isoprostanes following intravenous iron infusion in patients on hemodialysis, KIDNEY INT, 60(4), 2001, pp. 1525-1531
Authors:
Salahudeen, AK
Deogaygay, B
Fleischmann, E
Bower, JD
Citation: Ak. Salahudeen et al., Race-dependent survival disparity on hemodialysis: Higher serum aluminum as an independent risk factor for higher mortality in whites, AM J KIDNEY, 36(6), 2000, pp. 1147-1154
Authors:
Frazao, JM
Elangovan, L
Maung, HM
Chesney, RW
Acchiardo, SR
Bower, JD
Kelley, BJ
Rodriguez, HJ
Norris, KC
Robertson, JA
Levine, BS
Goodman, WG
Gentile, D
Mazess, RB
Kyllo, DM
Douglass, LL
Bishop, CW
Coburn, JW
Citation: Jm. Frazao et al., Intermittent doxercalciferol (1 alpha-hydroxyvitamin D-2) therapy for secondary hyperparathyroidism, AM J KIDNEY, 36(3), 2000, pp. 550-561
Authors:
Fleischmann, E
Teal, N
Dudley, J
May, W
Bower, JD
Salahudeen, AK
Citation: E. Fleischmann et al., Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients (vol 55, pg 1560, 1999), KIDNEY INT, 57(2), 2000, pp. 760-760
Citation: Ak. Salahudeen et al., Impact of lower delivered Kt/V on the survival of overweight patients on hemodialysis, KIDNEY INT, 56(6), 1999, pp. 2254-2259
Citation: Js. Berns et al., Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease, KIDNEY INT, 56(1), 1999, pp. 253-260
Authors:
Fleischmann, E
Teal, N
Dudley, J
May, W
Bower, JD
Salahudeen, AK
Citation: E. Fleischmann et al., Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients, KIDNEY INT, 55(4), 1999, pp. 1560-1567